Phase 1 Progesterone Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Triple-Negative Breast CancerGastric CancerOvarian Cancer+25 more

NiKang Therapeutics, Inc.150 enrolled19 locationsNCT06586957

Recruiting

Phase 1

First in Human Safety and Ease of Use Assessment of 400mg Progesterone Callavid in Women With Luteal Phase Insufficiency

Luteal Phase InsuffiencyProgesterone Delivery

Calla Lily Clinical Care Ltd20 enrolled1 locationNCT07136922

Recruiting

Phase 1

PRE-I-SPY Phase I/Ib Oncology Platform Program

Triple-Negative Breast CancerMetastatic Breast CancerHER2-low Breast Cancer+18 more

QuantumLeap Healthcare Collaborative124 enrolled7 locationsNCT05868226